Summary

AI-assisted Radiology Market Research Report Information by Technique (X-rays, Magnetic Resonance Imaging, Computed Tomography, Positron Emission Tomography (PET), and Others), by Application (Neurology, Mammography (Breast Cancer), Cardiovascular, Respiratory and Pulmonary, Orthopedics, and Others), by End User (Hospitals, Diagnostic Imaging Centers, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World - Forecast till 2032

Market Overview
The AI-assisted Radiology Market was valued at USD 1.57 billion in 2023. The AI-assisted Radiology Market is expected to increase from USD 2.03 billion in 2024 to USD 27.18 billion by 2032, with a compound yearly growth rate (CAGR) of 32.96% over the forecast period (2024-2032).
The expanding number of AI-powered medical imaging start-ups, as well as growing strategic endeavors by industry participants, are the primary drivers of the AI-assisted Radiology industry. However, high costs and limited resources are projected to impede global market expansion. Nonetheless, increased financing and investment for AI in medical imaging around the world is expected to provide profitable potential for the market.
The contemporary period is driving the use of AI in the medical imaging business. This is because the software enables professionals to diagnose diseases considerably faster and intervene earlier. Furthermore, emerging AI-powered start-ups are focusing on combining advanced capabilities into AI medical imaging products. Numerous AI-powered start-ups from around the world, including Viz.ai, Inc. (Israel), Aidoc (Israel), Lunit Inc. (South Korea), Suzhou Voxel Information Technology Co., Ltd. (China), and Arterys (US), are developing unique solutions to address physician demand. Furthermore, these start-ups are developing tactics to suit healthcare providers' demands.
As a result, an increasing number of AI-powered medical imaging start-ups are emerging to address various difficulties, provide improved outcomes, and help healthcare providers better understand diseases, hence fueling market growth.

Market Segment insights

AI-assisted Radiology Market segmentation by technology covers X-rays, magnetic resonance imaging, computed tomography, positron emission tomography (PET), and others.
The AI-assisted Radiology Market is divided into applications such as neurology, mammography (breast cancer), cardiovascular, respiratory and pulmonary, orthopedics, and others.
Hospitals, diagnostic imaging facilities, and others make up the end-user segment of the AI-assisted Radiology Market.

Regional insights
The study divides the market into four regions: North America, Europe, Asia-Pacific, and the rest of the world. The North American AI-assisted Radiology market is expanding rapidly due to a variety of variables. Advances in artificial intelligence (AI) and machine learning have altered radiology by enhancing diagnostic accuracy, simplifying procedures, and patient outcomes. This technological breakthrough addresses concerns such as increased demand for effective healthcare delivery amid rising chronic illness incidence and a radiology shortage.

The European AI-assisted Radiology market accounted for the second-largest market share due to well-established healthcare infrastructure and a developing healthcare industry, which drives the market. Furthermore, Germany AI-assisted Radiology providers are said to have the greatest market share, while France AI-assisted Radiology providers are expected to be the fastest expanding market in Europe.
The Asia-Pacific AI-assisted Radiology market is predicted to develop the fastest between 2024 and 2032, owing to increased expenditures in AI technology, the expansion of online retail channels for healthcare products, rising healthcare expenditure, and government initiatives and investments.

Major Players
Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), ContextVision AB (Sweden), GE Healthcare (US), FUJIFILM Corporation (Japan), Agfa-Gevaert Group (Belgium), ClariPi Inc (South Korea), Lunit Inc (South Korea), Enlitic Inc. (US), and NANO-X IMAGING LTD (Israel) are among the key companies in the AI-assisted Radiology market.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA FLOW
3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
3.5.1 PRIMARY RESEARCH DATA FLOW:
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
3.6.1 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
3.7.1 DATA FORECASTING TECHNIQUE
3.8 DATA MODELING
3.8.1 MICROECONOMIC FACTOR ANALYSIS:
3.8.2 DATA MODELING:
3.9 TEAMS AND ANALYST CONTRIBUTION
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 RISING NUMBER OF AI-POWERED MEDICAL IMAGING START- UPS
4.2.2 GROWING STRATEGIC INITIATIVES BY MARKET PLAYERS
4.3 RESTRAINTS
4.3.1 HIGH COST AND RESOURCE CONSTRAINTS
4.4 OPPORTUNITY
4.4.1 INCREASING FUNDING & INVESTMENT FOR AI IN MEDICAL IMAGING ACROSS THE GLOBE
5 MARKET FACTOR ANALYSIS
5.1 PORTER'S FIVE FORCES MODEL
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 BARGAINING POWER OF SUPPLIERS
5.1.3 THREAT OF SUBSTITUTES
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF RIVALRY
5.2 IMPACT OF COVID-19 ON THE GLOBAL AI IN RADIOLOGY MARKET
6 GLOBAL AI-ASSISTED RADIOLOGY MARKET, BY TECHNIQUE
6.1 OVERVIEW
6.2 X-RAYS
6.3 MAGNETIC RESONANCE IMAGING
6.4 COMPUTED TOMOGRAPHY (CT)
6.5 POSITRON EMISSION TOMOGRAPHY (PET)
6.6 OTHERS
7 GLOBAL AI-ASSISTED RADIOLOGY MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 NEUROLOGY
7.3 MAMMOGRAPHY (BREAST CANCER)
7.4 CARDIOVASCULAR
7.5 RESPIRATORY AND PULMONARY
7.6 ORTHOPEDICS
7.7 OTHERS
8 GLOBAL AI-ASSISTED RADIOLOGY MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITALS
8.3 DIAGNOSTIC IMAGING CENTERS
8.4 OTHERS
9 GLOBAL AI-ASSISTED RADIOLOGY, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 UK
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 CHINA
9.4.2 INDIA
9.4.3 JAPAN
9.4.4 AUSTRALIA
9.4.5 SOUTH KOREA
9.4.6 REST OF ASIA-PACIFIC
9.5 REST OF THE WORLD
9.5.1 MIDDLE EAST & AFRICA
9.5.2 SOUTH AMERICA
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 MARKET SHARE ANALYSIS, 2023
10.3 COMPETITOR DASHBOARD
10.4 PUBLIC PLAYERS STOCK SUMMARY
10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
10.6.1 PRODUCT LAUNCH/SERVICE LAUNCH
10.6.2 COLLABORATION
10.6.3 EXPANSION
10.6.4 AGREEMENT
10.6.5 PARTNERSHIP
11 COMPANY PROFILES
11.1 KONINKLIJKE PHILIPS N.V.
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGIES
11.2 SIEMENS HEALTHINEERS AG
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCTS OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.2.6 KEY STRATEGIES
11.3 CLARIPI INC
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 KEY STRATEGIES
11.4 CONTEXTVISION AB
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 KEY STRATEGIES
11.5 LUNIT INC.
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 KEY STRATEGIES
11.6 FUJIFILM HOLDINGS CORPORATION
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.6.6 KEY STRATEGIES
11.7 AGFA-GEVAERT GROUP
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 SOLUTIONS OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 SWOT ANALYSIS
11.7.6 KEY STRATEGIES
11.8 GE HEALTHCARE
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCTS OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 SWOT ANALYSIS
11.8.6 KEY STRATEGIES
11.9 ENLITIC, INC.
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 PRODUCTS OFFERED
11.9.4 KEY DEVELOPMENTS
11.9.5 KEY STRATEGIES
11.10 NANO-X IMAGING LTD.
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 PRODUCT/SOLUTIONS OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 KEY STRATEGIES